Is Vaxcyte Inc (NASDAQ: PCVX) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

PCVX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Vaxcyte Inc is $9.69B. A total of 0.75 million shares were traded on the day, compared to an average of 1.19M shares.

In the most recent transaction, Eydelman Mikhail sold 5,000 shares of PCVX for 70.74 per share on Mar 05 ’25. After the transaction, the SVP, GEN COUNSEL & CORP SEC now owns 41,620 company shares. In a previous transaction on Mar 05 ’25, Eydelman Mikhail bought 5,000 shares at 68.87 per share.

Among the insiders who sold shares, Wassil Jim disposed of 8,000 shares on Mar 03 ’25 at a per-share price of $73.27. This resulted in the CHIEF OPERATING OFFICER holding 154,931 shares of PCVX after the transaction. In another insider transaction, Wassil Jim bought 8,000 shares at $73.17 per share on Mar 03 ’25.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PCVX has a high of $121.06 and a low of $58.10.

As of this writing, PCVX has an earnings estimate of -$0.92 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.81 per share and a lower estimate of -$1.03.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PCVX’s latest balance sheet shows that the firm has $245.97M in Cash & Short Term Investments as of fiscal 2021. There were $16.78M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $26.47, while its Total Shareholder’s Equity was $284.02M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCVX is Buy with a score of 4.89.

Most Popular

Related Posts